Ancora Advisors’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $84.2K | Buy |
931
+106
| +13% | +$9.73K | ﹤0.01% | 959 |
|
|
2025
Q4 | $74.1K | Buy |
825
+385
| +88% | +$36.5K | ﹤0.01% | 1015 |
|
|
2025
Q3 | $43.3K | Buy |
440
+40
| +10% | +$3.96K | ﹤0.01% | 1062 |
|
|
2025
Q2 | $36.4K | Buy |
400
+173
| +76% | +$16.7K | ﹤0.01% | 1084 |
|
|
2025
Q1 | $25.7K | Buy |
227
+3
| +1% | +$321 | ﹤0.01% | 1146 |
|
|
2024
Q4 | $23.7K | Hold |
224
| – | – | ﹤0.01% | 1178 |
|
|
2024
Q3 | $24.2K | Hold |
224
| – | – | ﹤0.01% | 1159 |
|
|
2024
Q2 | $24.3K | Hold |
224
| – | – | ﹤0.01% | 1125 |
|
|
2024
Q1 | $29.6K | Sell |
224
-221
| -50% | -$27.6K | ﹤0.01% | 1106 |
|
|
2023
Q4 | $54.2K | Sell |
445
-125
| -22% | -$13.9K | ﹤0.01% | 927 |
|
|
2023
Q3 | $64K | Buy |
570
+221
| +63% | +$28.1K | ﹤0.01% | 862 |
|
|
2023
Q2 | $50.8K | Sell |
349
-8
| -2% | -$1.09K | ﹤0.01% | 905 |
|
|
2023
Q1 | $46.1K | Hold |
357
| – | – | ﹤0.01% | 928 |
|
|
2022
Q4 | $46K | Buy |
357
+32
| +10% | +$3.71K | ﹤0.01% | 989 |
|
|
2022
Q3 | $34K | Hold |
325
| – | – | ﹤0.01% | 1195 |
|
|
2022
Q2 | $34K | Hold |
325
| – | – | ﹤0.01% | 1291 |
|
|
2022
Q1 | $42K | Sell |
325
-10
| -3% | -$1.21K | ﹤0.01% | 1325 |
|
|
2021
Q4 | $41K | Sell |
335
-30
| -8% | -$3.93K | ﹤0.01% | 1356 |
|
|
2021
Q3 | $52K | Hold |
365
| – | – | ﹤0.01% | 1178 |
|
|
2021
Q2 | $57K | Hold |
365
| – | – | ﹤0.01% | 1060 |
|
|
2021
Q1 | $57K | Hold |
365
| – | – | ﹤0.01% | 1019 |
|
|
2020
Q4 | $55K | Hold |
365
| – | – | ﹤0.01% | 860 |
|
|
2020
Q3 | $48K | Hold |
365
| – | – | ﹤0.01% | 869 |
|
|
2020
Q2 | $42K | Buy |
365
+103
| +39% | +$11.9K | ﹤0.01% | 856 |
|
|
2020
Q1 | $26K | Sell |
262
-265
| -50% | -$34.7K | ﹤0.01% | 1013 |
|
|
2019
Q4 | $73K | Buy |
+527
| New | +$72.7K | ﹤0.01% | 826 |
|
|
2018
Q4 | – | Sell |
-1,470
| Closed | -$188K | – | 1209 |
|
|
2018
Q3 | $188K | Buy |
+1,470
| New | +$175K | 0.01% | 657 |
|
|
2018
Q1 | – | Sell |
-2,134
| Closed | -$250K | – | 704 |
|
|
2017
Q4 | $250K | Buy |
+2,134
| New | +$241K | 0.01% | 550 |
|
|
2017
Q1 | – | Sell |
-105
| Closed | -$10K | – | 1096 |
|
|
2016
Q4 | $10K | Buy |
+105
| New | +$11.3K | ﹤0.01% | 1049 |
|
Other funds holding ZBH
VCM
VPM
Ancora Advisors's ZBH Position: Q1 2026 in Review
Ancora Advisors increased its Zimmer Biomet (ZBH) stake by 13% in Q1 2026, buying an estimated $9.73K and bringing the position to 931 shares worth $84.2K. The position accounts for ﹤0.01% of the portfolio, ranked #959.
Ancora Advisors first reported a position in ZBH in Q4 2016 and has held it in 29 quarters since. The position peaked at $250K in Q4 2017. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- Ancora Advisors held 931 shares of Zimmer Biomet worth $84.2K as of Q1 2026.
- Ancora Advisors bought 106 Zimmer Biomet shares in Q1 2026, an estimated $9.73K.
- Zimmer Biomet made up ﹤0.01% of Ancora Advisors's portfolio in Q1 2026, its #959 holding.
- Ancora Advisors first reported a position in Zimmer Biomet in Q4 2016 and has held it in 29 quarters since.
- Ancora Advisors's Zimmer Biomet position peaked at $250K in Q4 2017.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on Ancora Advisors's 13F filing for Q1 2026, filed 15 May 2026.